Skip to main content

Table 4 Multivariate analysis

From: Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013

Prognostic factora

LC

LRC

DMFS

OS

HR (95 % CI)

p-value

HR (95 % CI)

p-value

HR (95 % CI)

p-value

HR (95 % CI)

p-value

Age (years)

 <65

NI

 

NI

 

1.0

 

1.0

 

 >65

    

1.2 (0.40–3.4)

0.793

0.89 (0.31–2.6)

0.836

Performance status (WHO)

 0

1.0

0.523

1.0

0.473

NI

 

1.0

0.022

 1

0.73 (0.24–2.2)

0.576

0.61 (0.23–1.6)

0.315

  

1.2 (0.52–2.9)

0.640

 2+3+4

1.9 (0.31–12)

0.483

1.4 (0.25–7.6)

0.722

  

7.7 (1.7–34)

0.008

Site

 SN

2.1 (0.52–8.7)

0.298

2.1 (0.64–7.4)

0.216

NI

 

NI

 

 OC-OP

1.0

 

1.0

     

Pigmented lesion

 Yes

NI

 

NI

 

1.0

 

NI

 

 No

    

1.2 (0.40–3.4)

0.779

  

Treatment modality

 Surgery

2.2 (0.42–12)

0.355

4.7 (0.98–22)

0.054

NI

 

1.0 (0.46–2.2)

0.979

 RT

11 (2.1–63)

0.005

16 (3.0–80)

0.001

  

2.0 (0.73–5.5)

0.175

 surgery+PORT

1.0

0.005

1.0

0.002

  

1.0

0.303

Systemic therapy

 Yes

NI

 

NI

 

1.0

 

1.0

 

 No

    

2.6 (0.62–11)

0.193

3.1 (0.92–10)

0.068

  1. aFactors with no statistical significance in univariate analysis were included if deemed clinically relevant
  2. NI not included in multivariate analysis, LC Local control, LRC Locoregional control, DMFS Distant metastasis-free survival, OS Overall survival, WHO World Health Organization, SN Sinonasal, OC-OP Oral cavity/oropharynx, RT Radiotherapy, PORT Postoperative radiotherapy